BE657527A - - Google Patents

Info

Publication number
BE657527A
BE657527A BE657527A BE657527A BE657527A BE 657527 A BE657527 A BE 657527A BE 657527 A BE657527 A BE 657527A BE 657527 A BE657527 A BE 657527A BE 657527 A BE657527 A BE 657527A
Authority
BE
Belgium
Application number
BE657527A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE657527A publication Critical patent/BE657527A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE657527A 1963-12-24 1964-12-23 BE657527A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1594463A CH464204A (de) 1963-12-24 1963-12-24 Verfahren zur Herstellung neuer Isoxazole
CH1375764 1964-10-23

Publications (1)

Publication Number Publication Date
BE657527A true BE657527A (de) 1965-06-23

Family

ID=25713013

Family Applications (1)

Application Number Title Priority Date Filing Date
BE657527A BE657527A (de) 1963-12-24 1964-12-23

Country Status (7)

Country Link
US (1) US3277105A (de)
BE (1) BE657527A (de)
CH (1) CH464204A (de)
DE (1) DE1445645A1 (de)
FR (2) FR1437414A (de)
GB (1) GB1045819A (de)
NL (1) NL6415014A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345375A (en) * 1963-03-25 1967-10-03 Squibb & Sons Inc 3-lower alkyl-5-(4-pyridyl)-isoxazole-4-carbonyl derivatives
CH481132A (de) * 1966-06-09 1969-11-15 Ciba Geigy Verfahren zur Herstellung von neuen Isoxazolen
US3546231A (en) * 1968-05-03 1970-12-08 Ansul Co Certain 2-(pyridyl-3-thiocarbamoyl-1,3-oxazolidines)
US6136828A (en) * 1996-02-01 2000-10-24 Smithkline Beecham Corporation Endothelin receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE569324A (de) * 1957-07-11

Also Published As

Publication number Publication date
CH464204A (de) 1968-10-31
NL6415014A (de) 1965-06-25
US3277105A (en) 1966-10-04
FR4041M (de) 1966-03-28
FR1437414A (fr) 1966-05-06
DE1445645A1 (de) 1968-12-19
GB1045819A (en) 1966-10-19

Similar Documents

Publication Publication Date Title
FR4041M (de)
BE627012A (de)
BE625828A (de)
BE614220A (de)
BE645695A (de)
BE644251A (de)
BE643273A (de)
BE643161A (de)
BE603935A (de)
BE643039A (de)
BE642721A (de)
BE642603A (de)
BE642344A (de)
BE635158A (de)
BE631244A (de)
BE627172A (de)
BE627151A (de)
BE627145A (de)
BE627141A (de)
BE627083A (de)
BE627025A (de)
BE627023A (de)
BE626986A (de)
BE626938A (de)
BE608372A (de)